This week, we highlight the upcoming Open Access Summit and 20th Annual Meeting of ISMPP. We learn about the use of ORCID to assess research quality, and we explore reflections on the UNESCO open science outlook. We also read the results of a survey on the future of peer review and a summary of day two of the 2024 European Meeting of ISMPP. Finally, we share price and service transparency data from PLOS.
To engage with:
Open Access Summit 2024 via Open Access Summit
On 20 and 21 March, the Open Society University Network and Central European University will host their 2024 Open Access Summit in Vienna, Austria. This free, open-to-all event will give delegates the opportunity to explore topics including open access (OA) publishing models, global OA challenges and opportunities, and transparency in academic publishing. A full schedule can be found on the meeting website and registration is open now.
20th Annual Meeting of ISMPP via ISMPP
Registration for the 20th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) is now open! The theme of this year’s meeting – which will take place in Washington, DC, USA, from 28 April to 1 May – is Storytelling: Its Art and Power. Open Pharma is pleased to be hosting two roundtables at the meeting, titled Where are the data? A shared view on data sharing and The rapidly changing face of open access. Registration is open until 12 April. We look forward to seeing you there!
To read:
ORCID as an indicator of research quality via The Scholarly Kitchen | 5-minute read
In this post for The Scholarly Kitchen, Richard Wynne (Founder of Rescognito) considers an Open Researcher and Contributor iD (ORCID) use case relating to scholarly retractions. Richard argues that journals should use persistent identifiers and associated metadata as ‘quality signals’. These would highlight works submitted by authors with a history of research malpractice and retractions that may warrant extra scrutiny from editors. More information about ORCID can be found in the Open Pharma ORCID toolkit and infographic.
Reflecting on the UNESCO open science outlook via Nature | 4-minute read
In 2021, the United Nations Educational, Scientific and Cultural Organization (UNESCO) published its Recommendation on Open Science. Following the recent publication of its Open science outlook 1: status and trends around the world update report, this editorial from Nature reflects on the global progress made towards open science since 2021, and the areas in which work still needs to be done.
AI and the future of peer review via The Scholarly Kitchen | 8-minute read
As artificial intelligence (AI) use continues to increase, professionals across the scholarly publications landscape are exploring how this technology could revolutionize the sector. In this article, Roohi Ghosh (Ambassador – Researcher Outreach, Engagement and Success at Cactus Communications) summarizes the results of a global survey that collected insights on the future of peer review. The survey found that, although AI has the potential to transform the peer review process, stakeholders are concerned about data privacy, bias and transparency. Read the full results of the survey in this article published in Learned Publishing.
Report from day two of the 2024 European Meeting of ISMPP via The Publication Plan | 25-minute read
Taking place on 23 and 24 January in London, UK, the theme of the 2024 European Meeting of ISMPP was Innovation: the new tradition. This summary by The Publication Plan provides an overview of day two of the meeting, including sessions on stakeholder compensation, best publication practices and the ACcurate COnsensus Reporting Document (ACCORD) checklist. The summary from day one was highlighted in last week’s Open Pharma weekly digest.
PLOS price transparency data via PLOS Blogs | 5-minute read
The non-profit OA publisher PLOS has released its annual reporting from the Plan S Price & Service Transparency Framework for 2022. The reporting includes a breakdown of article processing charges (APCs) for all PLOS journals and indicates how these charges are used to fund journal services.
Enjoy reading our content? Then make sure to follow us on Twitter/X and LinkedIn for regular updates!
